RANI Third Quarter Update
| TNYA Stock | USD 0.64 0.05 7.25% |
About 60% of Tenaya Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Tenaya Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Tenaya Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Tenaya Therapeutics stock news signals to limit their universe of possible portfolio assets.
Tenaya |
By John Vandermosten, CFA NASDAQRANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. reported third quarter 2024 results on November 14 th , 2024. Since the second quarter report, Rani has participated in multiple investor conferences, raised an additional 10 million and reported data for a GLP-1 incretin triagonist, which we review below. We are looking ahead
Read at finance.yahoo.com
 |
Tenaya Therapeutics Fundamental Analysis
We analyze Tenaya Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tenaya Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tenaya Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Tenaya Therapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Tenaya Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tenaya Therapeutics stock to make a market-neutral strategy. Peer analysis of Tenaya Therapeutics could also be used in its relative valuation, which is a method of valuing Tenaya Therapeutics by comparing valuation metrics with similar companies.
Peers
Tenaya Therapeutics Related Equities
| RANI | Rani Therapeutics | 1.49 | ||||
| GOSS | Gossamer Bio | 0.86 | ||||
| CRVS | Corvus Pharmaceuticals | 0.30 | ||||
| AKRO | Akero Therapeutics | 1.97 | ||||
| OCUL | Ocular Therapeutix | 2.19 | ||||
| BCYC | Bicycle Therapeutics | 2.39 | ||||
| GLUE | Monte Rosa | 3.04 | ||||
| IGMS | IGM Biosciences | 3.13 | ||||
| STOK | Stoke Therapeutics | 3.22 | ||||
| DRTS | Alpha Tau | 3.76 | ||||
| VINC | Vincerx Pharma | 5.26 | ||||
| ALXO | Alx Oncology | 7.04 | ||||
| INZY | Inozyme Pharma | 7.07 | ||||
| BMEA | Biomea Fusion | 7.63 | ||||
| EYEN | Eyenovia | 10.32 |
Complementary Tools for Tenaya Stock analysis
When running Tenaya Therapeutics' price analysis, check to measure Tenaya Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenaya Therapeutics is operating at the current time. Most of Tenaya Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenaya Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenaya Therapeutics' price. Additionally, you may evaluate how the addition of Tenaya Therapeutics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |